Settle down guys - here are the facts !! ........
Prima has done 5 phase I studys on CVac until they found what worked. Then they completed a phase II study and are doing a second phase IIb for a ?Potency Assay? and to comply with US FDA IND. The phase III will provide ?statistical significance for US FDA and EU EMA approval?
On Abagovomab see this news
http://www.medpagetoday.com/MeetingCoverage/ASCO/26956
For Abagovomab mode of delivery(CA-125 monoclonal antibody) mimicked the previously failed phase III study of Oregovomab in 2009
See article on Oregovomab
http://jco.ascopubs.org/content/27/3/418.full
Notice the author is Dr Jonathan Berek on why Oregovomab failed. The expert call from Dr Berek on why CVac is a winner
Listen to this opinion on
http://www.investorcalendar.com/IC/CEPage.asp?ID=163542
- Forums
- ASX - By Stock
- abagovomab vs oregovomab - facts ...
Settle down guys - here are the facts !! ........Prima has done...
-
- There are more pages in this discussion • 1 more message in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add IMM (ASX) to my watchlist
(20min delay)
|
|||||
Last
39.0¢ |
Change
-0.005(1.27%) |
Mkt cap ! $569.8M |
Open | High | Low | Value | Volume |
40.0¢ | 40.0¢ | 39.0¢ | $318.0K | 806.0K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
22 | 641983 | 39.0¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
39.5¢ | 313126 | 22 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
23 | 649273 | 0.390 |
14 | 374865 | 0.385 |
22 | 652193 | 0.380 |
6 | 321105 | 0.375 |
12 | 535028 | 0.370 |
Price($) | Vol. | No. |
---|---|---|
0.395 | 320878 | 23 |
0.400 | 77927 | 13 |
0.405 | 63916 | 5 |
0.410 | 304517 | 7 |
0.415 | 115650 | 2 |
Last trade - 13.24pm 19/06/2024 (20 minute delay) ? |
Featured News
IMM (ASX) Chart |
The Watchlist
P.HOTC
HotCopper
Don Currie, CEO
Don Currie
CEO
Previous Video
Next Video
SPONSORED BY The Market Online